Recent Publications

Recent Publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013

2024

Apr 08, 2024
Maezawa, M., Watanabe, K. I., Kobayashi, Y., Yoshida, K., Chambers, J. K., Uchida, K., Maruyama, R. and Inokuma, H.
Diffuse large B-cell lymphoma with DNA copy number changes in a Japanese black calf.
Veterinary research communications, in press (2024)
Mar 21, 2024
Chuaychob, S., Lyu, R., Tanaka, M., Haginiwa, A., Kitada, A., Nakamura, T. and Yokokawa, R.
Mimicking angiogenic microenvironment of alveolar soft-part sarcoma in a microfluidic coculture vasculature chip.
Proc. Natl. Acad. Sci. U. S. A., 121, e2312472121 (2024)
Mar 07, 2024
Okawa, H., Tanaka, Y. and Takahashi, A.
Network of extracellular vesicles surrounding senescent cells.
Archives of biochemistry and biophysics, in press (2024)

Mar 04, 2024
Yang, L., Kumegawa, K., Saeki, S., Nakadai, T. and Maruyama, R.
Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines.
Cancer gene therapy, in press (2024)
Feb 26, 2024
Suzuki, M., Uchibori, K., Oh-Hara, T., Nomura, Y., Suzuki, R., Takemoto, A., Araki, M., Matsumoto, S., Sagae, Y., Kukimoto-Niino, M., Kawase, Y., Shirouzu, M., Okuno, Y., Nishio, M., Fujita, N. and Katayama, R.
A macrocyclic kinase inhibitor overcomes triple resistant mutations in EGFR-positive lung cancer.
NPJ Precis. Oncol., 8, 46 (2024)
Feb 19, 2024
Shirahama, H., Tani, Y., Tsukahara, S., Okamoto, Y., Hasebe, A., Noda, T., Ando, S., Ushijima, M., Matsuura, M. and Tomida, A.
Induction of stearoyl-CoA desaturase confers cell density-dependent ferroptosis resistance in melanoma.
J. Cell. Biochem., in press (2024)
Feb 15, 2024
Kawano, T., Okamura, K., Shinchi, H., Ueda, K., Nomura, T. and Shiba, K.
Differentiation of large extracellular vesicles in oral fluid: Combined protocol of small force centrifugation and sedimentation pattern analysis.
Journal of Extracellular Biology, 3, e143 (2024)
Jan 24, 2024
Hirose, S., Mashima, T., Yuan, X., Yamashita, M., Kitano, S., Torii, S., Migita, T. and Seimiya, H.
Interleukin-4 induced 1-mediated resistance to an immune checkpoint inhibitor through suppression of CD8+ T cell infiltration in melanoma.
Cancer Sci., in press (2024)
Jan 24, 2024
Yonemura, A., Semba, T., Zhang, J., Fan, Y., Yasuda-Yoshihara, N., Wang, H., Uchihara, T., Yasuda, T., Nishimura, A., Fu, L., Hu, X., Wei, F., Kitamura, F., Akiyama, T., Yamashita, K., Eto, K., Iwagami, S., Iwatsuki, M., Miyamoto, Y., Matsusaki, K., Yamasaki, J., Nagano, O., Saya, H., Song, S., Tan, P., Baba, H., Ajani, J. A. and Ishimoto, T.
Mesothelial cells with mesenchymal features enhance peritoneal dissemination by forming a protumorigenic microenvironment.
Cell Rep, in press (2023)
Jan 22, 2024
Tani, T., Mathsyaraja, H., Campisi, M., Li, Z. H., Haratani, K., Fahey, C. G., Ota, K., Mahadevan, N. R., Shi, Y., Saito, S., Mizuno, K., Thai, T. C., Sasaki, N., Homme, M., Yusuf, C. F. B., Kashishian, A., Panchal, J., Wang, M., Wolf, B. J., Barbie, T. U., Paweletz, C. P., Gokhale, P. C., Liu, D., Uppaluri, R., Kitajima, S., Cain, J. and Barbie, D. A.
TREX1 inactivation unleashes cancer cell STING-interferon signaling and promotes anti-tumor immunity.
Cancer Discov., in press (2024)
Jan 15, 2024
Kimura, N., Tanaka, Y., Yamanishi, Y., Takahashi, A. and Sakuma, S.
Nanoparticles based on natural-lipids reveal extent of impacts of designed physical characteristics on biological functions.
ACS Nano, in press (2024)
Jan 12, 2024
Morino, S., Mashima, T., Shirai, F., Nagayama, S., Katayama, R. and Seimiya, H.
BET protein–dependent E2F pathway activity confers bell-shaped type resistance to tankyrase inhibitors in APC-mutated colorectal cancer.
Cancer Lett, in press (2024)
Jan 09, 2024
Murayama, T., Nakayama, J., Jiang, X., Miyata, K., Morris, A. D., Cai, K. Q., Prasad, R. M., Ma, X., Efimov, A., Belani, N., Gerstein, E. R., Tan, Y., Zhou, Y., Kim, W., Maruyama, R., Campbell, K. S., Chen, L., Yang, Y., Balachandran, S. and Canadas, I.
Targeting DHX9 triggers tumor-intrinsic interferon response and replication stress in small cell lung cancer.
Cancer Discov, in press (2024)

Return to Top of Page